NTRK Fusion Cancer Therapy
Discover precision oncology at Appleglc.com with NTRK fusion cancer resources — larotrectinib, entrectinib, and next-generation TRK inhibitor guidance across all tumour types.
Vitrakvi
Larotrectinib Sulfate
Rozlytrek
Entrectinib
Keytruda
Pembrolizumab
Opdivo
Nivolumab
Tecentriq
Atezolizumab
Imfinzi
Durvalumab
Bavencio
Avelumab
Libtayo
Cemiplimab-rwlc
Loqtorzi
Toripalimab-tpzi
Tevimbra
Tislelizumab-jsgr
Opdualag
Nivolumab and Relatlimab-rmbw
Avastin
Bevacizumab
Mvasi
Bevacizumab-awwb
Zirabev
Bevacizumab-bvzr
Cyramza
Ramucirumab
Taxol
Paclitaxel
Taxotere
Docetaxel
Abraxane
Paclitaxel Protein-Bound Particles
Platinol
Cisplatin
Paraplatin
Carboplatin
Eloxatin
Oxaliplatin
Gemzar
Gemcitabine Hydrochloride
Xeloda
Capecitabine
Adrucil
Fluorouracil Injection
Camptosar
Irinotecan Hydrochloride
Retevmo
Selpercatinib
Gavreto
Pralsetinib
Augtyro
Repotrectinib
Tabrecta
Capmatinib
Tepmetko
Tepotinib
Lumakras
Sotorasib
Krazati
Adagrasib
Rybrevant
Amivantamab-vmjw
Pemazyre
Pemigatinib
Lytgobi
Futibatinib
Enhertu
Fam-Trastuzumab Deruxtecan-nxki
Kadcyla
Ado-trastuzumab Emtansine
Trodelvy
Sacituzumab Govitecan-hziy
Padcev
Enfortumab Vedotin
Lonsurf
Trifluridine and Tipiracil Hydrochloride